Tychon Biosciences LLC — Form D
Tychon Biosciences LLC of MINNEAPOLIS, MN, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-17. The offering totals $3.0M, of which $200K was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-10-17
- Form: D
- Accession: 0001235802-18-000156
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $200K
- Remaining: $2.8M
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2018-10-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-323772
Issuer
- Name: Tychon Biosciences LLC
- CIK: 0001659363
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 807 Broadway Street NE, MINNEAPOLIS, MN, 55413
- Phone: 612-200-1039
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Danny J Cunagin | Director | Minneapolis, MN |
| Troy D Kopischke | Director | Minneapolis, MN |
| Danny J Cunagin | Executive Officer | Minneapolis, MN |
| Arek Z Dudek, MD PhD | Executive Officer | Minneapolis, MN |
| Troy D Kopischke | Executive Officer | Minneapolis, MN |
| John Z MacDonald, PhD | Executive Officer | Minneapolis, MN |
| Charles J Muscoplat, PhD | Executive Officer | Minneapolis, MN |
| Mark Z Sylvester | Executive Officer | Minneapolis, MN |
| Mark D Sylvester | Executive Officer | Minneapolis, MN |
Other filings by this issuer (1)
More